Antisecretory factor counteracts secretory diarrhoea of endocrine origin.
BACKGROUND
Dietary induction of antisecretory factor (AF) can reduce diarrhoea in patients with inflammatory bowel disease. Patients with neuroendocrine tumours may suffer from diarrhoea with a prominent secretory component. We studied if AF-therapy could affect this type of diarrhoea.


METHODS
Six patients with the midgut carcinoid syndrome and two with metastasizing medullary thyroid carcinoma (MTC) participated. Effects of intake of AF, in the form of AF-rich egg powder (AF-egg), and induction of endogenous AF-activity by intake of specially processed cereals (SPCs) were studied. In an initial open part of the study all patients received AF-egg for 4 weeks, followed by a double-blind crossover period with SPC and control cereals (CCs) for 6 weeks each. Daily number of bowel movements at the end of each treatment period was registered.


RESULTS
Treatment with AF-egg resulted in a decrease of bowel movements in seven patients (P<0.01). Registrations of bowel movements from both SPC and CC diet periods were obtained from five patients. The daily number of bowel movements was lower during the SPC-period compared to the period with CC (P<0.05). All patients had low levels of AF-activity in serum at baseline. During treatment with AF-egg, the mean level increased slightly. AF-activity was higher (P<0.05) after SPC compared to the CC diet.


CONCLUSIONS
In a group of patients with endocrine diarrhoea, AF-activity could be induced, and AF-therapy reduced the number of bowel movements.
Laurenius
A
A
Department of Clinical Nutrition, Göteborg University, Göteborg, Sweden.
Wängberg
B
B
Lange
S
S
Jennische
E
E
Lundgren
B K
BK
Bosaeus
I
I
D000930:Antidiarrheals / Q000494:pharmacology*; D018276:Carcinoma, Medullary / Q000473:pathology / Q000503:physiopathology*; D018592:Cross-Over Studies; D003967:Diarrhea / Q000178:diet therapy*; D004311:Double-Blind Method; D002523:Edible Grain; D004530:Egg Yolk; D004702:Endocrine Glands / Q000378:metabolism / Q000503:physiopathology*; D005260:Female; D019648:Foods, Specialized; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000473:pathology / Q000503:physiopathology*; D008875:Middle Aged; D009479:Neuropeptides / Q000008:administration & dosage / Q000494:pharmacology*; D013964:Thyroid Neoplasms / Q000473:pathology / Q000503:physiopathology*
D000930:Antidiarrheals; D009479:Neuropeptides; C049628:antisecretory factor